Optimer Pharmaceuticals , NYSE: OPTR
Developing antibiotics to treat gastrointestinal diseases, including diarrhea.
Industry: Health Care
First Day Return: +21.4%
Industry: Health Care
OPTR
Developing antibiotics to treat gastrointestinal diseases, including diarrhea.
| IPO Data | |
|---|---|
| IPO File Date | 11/09/2006 |
| Offer Price | $7.00 |
| Price Range $12.00 - $14.00 | |
| Offer Shares (mm) | 7.0 |
| Deal Size ($mm) | $49 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 02/08/2007 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $49 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | San Diego, CA, United States |
| Founded | 1998 |
| Employees at IPO | 42 |
| Website www.optimerpharma.com | |
IPO News for Optimer Pharmaceuticals
Optimer Pharmaceuticals (OPTR) Performance
